Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients

Hepatology

Volumn 26, Issue 2, 1997, Pages 491-494

  Feucht, Heinz Hubert ^a   Zöllner, Bernhard ^a   Polywka, Susanne ^a   Knödler, Bärbel ^a   Schröter, Matthias ^a   Nolte, Hartmut ^b   Laufs, Rainer ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Hospital Pinneberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS ANTIBODY; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HEPATITIS VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VIREMIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RISK FACTORS; VIRAL PROTEINS; VIREMIA;

EID: 0030833851     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260234     Document Type: Article

References (26)

1. Linnen J, Wages J Jr., Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-569.
3. Leary TP, Muerhoff SM, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67.
4. Feucht HH, Zöllner B, Laufs R. Comparison of conventional autoradiography with a new DNA enzyme immunoassay for the detection of hepatitis C virus-polymerase chain reaction amplification products J Virol Methods 1995;55:105-110.
5. Reuter D, Polywka S, Iske L, Feucht HH, Laufs R. Close correlation between hepatitis C virus serology and polymerase chain reaction in chronically infected patients. Infection 1992;20:320-323.
6. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong D, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
7. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-5467.
8. Feucht HH, Zöllner B, Polywka S, Laufs R. Study on the reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol 1995;33:620-624.
9. Marin MG, Bresciani S, Puoti M, Rodella A, Gussago A, Ravaggi A, et al. Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection. J Clin Microbiol 1994;32:3008-3012.
10. Young KKY, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol 1995;33:654-657.
11. Dawson GJ, Schlauder GG, Coleman P, Gabriel G, Anderson D, Leahy D, Desai SM, et al. Prevalence and clinical significance of GBV-C [Abstract]. IX triennial international symposium on viral hepatitis and liver disease, Rome 1996, abstract 116.
12. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A 1990;87:2057-2061.
13. Ohba K, Mizokami M, Lau JY, Orito E, Ikeo K, Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatits agents. FEBS Lett 1996;378:232-234.
14. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludiam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma. Lancet 1996;348:1352-1355.
15. Dawson GJ, Lesniewski RR, Stewart JL, Boardway KM, Guitierrez RA, Pendy L, Johnson RG, et al. Detection of antibodies to hepatitis C virus in U.S. blood donors. J Clin Microbiol 1991;29:551-556.
16. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander \VJ, Hu PY, et al. The natural history of community- acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
17. Liang TJ, Bodenheimer HC Jr., Yankee R, Brown NV, Chang K, Huang J, Wands JR. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994;42:151-157.
18. Crawford RJ, Gillon J, Yap PL, Brookes E, McOmish F, Simmonds P, Dow BC, et al. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med 1994;4:121-124.
19. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996;347:909.
20. Feucht HH, Zöllner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet 1996;347:615-616.
21. Feucht HH, Polywka S, Zöllner B, Laufs R. Greater amount of HCVRNA in tears compared to blood. Microbiol Immunol 1994;38:157-158.
22. Feucht HH, Zöllner B, Schröter M, Altrogge H, Laufs R. Tear fluid of hepatitis C virus carriers could be infectious. J Clin Microbiol 1995;33:2202-2203.
23. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-1132.
24. Zaidi Y, Chapman CS, Myint S. Aplastic anaemia after HGV infection. Lancet 1996;348:471-472.
25. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Böker K, Muerhoff S, Mushawar IK, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348:1626-1629.
26. Feucht HH, Fischer L, Sterneck M, Knödler B, Broelsch CE, Laufs R. GB virus C infection and liver transplantation: increased risk of transfusiontransmitted infection. Blood 1997;89:2223-2224.